Evaluation of muscle weakness, function and quality of life after Intensive Care Unit discharge in survivors of COVID-19
Not Applicable
Recruiting
- Conditions
- Coronavirus infection, unspecified Coronavirus as the cause of diseases classified to other chaptersB34.2B97.2
- Registration Number
- RBR-564y4n
- Lead Sponsor
- Instituto de Assistência Médica ao Servidor Público Estadual
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Both sexes; aged 18 years and above; confirmed diagnosis of COVID-19; treatment with invasive mechanical ventilation; survivors during the hospitalization period, and discharge from the ICU.
Exclusion Criteria
Primary cause of using invasive mechanical ventilation is not pneumonia caused by COVID-19; not be subjected to invasive mechanical ventilation; death during the ICU stay; inability to understand verbal commands and altered level of consciousness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of this study will be the prevalence of intensive care unit acquired muscle weakness in survivors of COVID-19, assessed using the Medical Research Council scale.
- Secondary Outcome Measures
Name Time Method Secondary outcomes will be as follows: <br><br>- Peripheral muscle strength<br>- Patients' frailty<br>- Functional capacity <br>- Quality of life